Stabilization of IGFBP-1 mRNA by ethanol in hepatoma cells involves the JNK pathway

J Hepatol. 2007 Nov;47(5):691-8. doi: 10.1016/j.jhep.2007.05.018. Epub 2007 Jun 27.

Abstract

Background/aims: Insulin-like growth factor-binding protein-1 (IGFBP-1) modulates cell growth and metabolism in a variety of physiopathological conditions. The aim of this study was to determine the molecular mechanisms involved in IGFBP-1 upregulation by ethanol.

Methods: We studied IGFBP-1 regulation by ethanol at the protein, mRNA and gene promoter levels in the human hepatocarcinoma cell line, HepG2, which does not express significantly ethanol-metabolizing enzymes.

Results: Ethanol (35-150mM) induced the IGFBP-1 mRNA and protein up to 5-fold in a dose-dependent manner. A similar effect was observed using primary cultures of human hepatocytes. Various inhibitors of ethanol metabolism and the antioxidant N-acetylcysteine did not prevent ethanol effects. While ethanol did not modify the IGFBP-1 gene promoter activity, it elicited a 2- to 3-fold increase in IGFBP-1 mRNA half-life and this stabilization required the 5' and the 3' untranslated mRNA region. Ethanol triggered a rapid activation of c-Jun N-terminal Kinase (JNK) in HepG2 cells and IGFBP-1 induction was significantly decreased by a specific inhibitor of JNK.

Conclusions: This study reveals a novel pathway of gene regulation by alcohol which involves the activation of JNK and the consequent mRNA stabilization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants / pharmacology
  • Carcinoma, Hepatocellular / metabolism
  • Cell Line, Tumor
  • Central Nervous System Depressants / pharmacology
  • Dose-Response Relationship, Drug
  • Enzyme Activation / drug effects
  • Enzyme Activation / genetics
  • Ethanol / pharmacology*
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / genetics
  • Hepatocytes / drug effects*
  • Hepatocytes / metabolism
  • Humans
  • Insulin-Like Growth Factor Binding Protein 1 / genetics*
  • Insulin-Like Growth Factor Binding Protein 1 / metabolism
  • JNK Mitogen-Activated Protein Kinases / drug effects*
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Liver / drug effects*
  • Liver / metabolism
  • Liver Neoplasms / metabolism
  • Promoter Regions, Genetic / drug effects
  • Promoter Regions, Genetic / genetics
  • RNA Stability / drug effects*
  • RNA Stability / genetics
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Up-Regulation / drug effects
  • Up-Regulation / genetics

Substances

  • Antioxidants
  • Central Nervous System Depressants
  • IGFBP1 protein, human
  • Insulin-Like Growth Factor Binding Protein 1
  • RNA, Messenger
  • Ethanol
  • JNK Mitogen-Activated Protein Kinases